These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1833553)

  • 1. Serotonergic treatment for aggression in a Down's syndrome adult showing signs of Alzheimer's disease.
    Gedye A
    J Ment Defic Res; 1991 Jun; 35 ( Pt 3)():247-58. PubMed ID: 1833553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of trazodone in Alzheimer's disease.
    Lebert F; Pasquier F; Petit H
    J Clin Psychiatry; 1994 Dec; 55(12):536-8. PubMed ID: 7814348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
    Mintzer JE
    J Clin Psychiatry; 2001; 62 Suppl 21():23-5. PubMed ID: 11584984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].
    Kitamura Y; Kudo Y; Imamura T
    No To Shinkei; 2006 Jun; 58(6):483-8. PubMed ID: 16856516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials.
    Blackwood DH; St Clair DM; Muir WJ; Oliver CJ; Dickens P
    J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():439-53. PubMed ID: 2976841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
    Hemingway-Eltomey JM; Lerner AJ
    Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
    [No Abstract]   [Full Text] [Related]  

  • 10. Down's syndrome and its association with Alzheimer's disease.
    Yatham LN; McHale PA; Kinsella A
    Acta Psychiatr Scand; 1988 Jan; 77(1):38-41. PubMed ID: 2964773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil for Down's syndrome.
    Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract]   [Full Text] [Related]  

  • 12. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four year prospective study of age-related cognitive change in adults with Down's syndrome.
    Oliver C; Crayton L; Holland A; Hall S; Bradbury J
    Psychol Med; 1998 Nov; 28(6):1365-77. PubMed ID: 9854278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The link between Down's syndrome and Alzheimer's disease: 1.
    Soliman A; Hawkins D
    Br J Nurs; 1998 Jul 9-22; 7(13):779-84. PubMed ID: 9732570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thyroid stimulating hormone on adaptive behaviour in Down's syndrome.
    Bhaumik S; Collacott RA; Garrick P; Mitchell C
    J Ment Defic Res; 1991 Dec; 35 ( Pt 6)():512-20. PubMed ID: 1839315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.